Robert F. Kennedy Jr. on glyphosate: what the evidence says · JRE #2461
SUBJECT: GLYPHOSATE
The short answer
Kennedy claims Bayer/Monsanto has paid $11 billion, is about to sign an additional $7.6 billion Roundup settlement, faces 65,000 pending cases, and has said it will exit the glyphosate business without legal relief. Public reporting confirms the general scale of Bayer's Roundup litigation but not the precise figures Kennedy cites.
Not a true/false call. Every claim is logged with its sources; read the exhibits below.
the company that's making this has paid $11 billion in my lawsuit. They're just about to sign another $7. 6 billion settlement. There's 65,000 cases out there, and they've said, We're getting out of this business.
What the evidence says 01 / RECORD
Public reporting confirms the general scale of Bayer's Roundup litigation but not the precise figures Kennedy cites. Reuters reported in February 2026 that Bayer had previously paid about $10 billion (not $11 billion) to settle most Roundup lawsuits pending as of 2020, and that it proposed a new class-action settlement worth up to $7.25 billion (not $7.6 billion), which as of a June 30, 2026 hearing-date update was still awaiting court approval (an August 19 hearing) rather than "about to be signed." The 65,000-case figure is accurate: Reuters reports approximately 65,000 pending state and federal Roundup claims (AP separately cites about 200,000 total claims ever filed against Bayer, a different, larger cumulative figure). Bayer has already stopped selling glyphosate-based Roundup for the U.S. residential lawn-and-garden market and has said it "might have to consider" pulling glyphosate from U.S. agricultural markets if litigation continues, but this is a conditional statement rather than the flat declaration "we're getting out of this business" Kennedy attributes to the company. A June 2026 Supreme Court ruling in Bayer's favor has since reduced the near-term litigation pressure that would drive such an exit.